Chevy Chase Trust Holdings LLC cut its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 3.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 306,915 shares of the financial services provider’s stock after selling 10,220 shares during the quarter. Chevy Chase Trust Holdings LLC’s holdings in MetLife were worth $25,130,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds also recently made changes to their positions in the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of MetLife by 1.5% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,548,725 shares of the financial services provider’s stock valued at $375,179,000 after purchasing an additional 68,579 shares in the last quarter. Nordea Investment Management AB boosted its position in shares of MetLife by 16.8% during the fourth quarter. Nordea Investment Management AB now owns 4,238,087 shares of the financial services provider’s stock valued at $347,735,000 after purchasing an additional 608,224 shares in the last quarter. Swedbank AB boosted its position in shares of MetLife by 76.0% during the fourth quarter. Swedbank AB now owns 3,466,808 shares of the financial services provider’s stock valued at $283,862,000 after purchasing an additional 1,496,645 shares in the last quarter. Jennison Associates LLC boosted its position in shares of MetLife by 3.6% during the fourth quarter. Jennison Associates LLC now owns 3,274,258 shares of the financial services provider’s stock valued at $268,096,000 after purchasing an additional 114,166 shares in the last quarter. Finally, Stifel Financial Corp boosted its position in shares of MetLife by 5.0% during the third quarter. Stifel Financial Corp now owns 2,239,841 shares of the financial services provider’s stock valued at $184,744,000 after purchasing an additional 105,762 shares in the last quarter. 94.99% of the stock is currently owned by institutional investors.
MetLife Stock Down 0.7 %
MET stock opened at $81.78 on Friday. MetLife, Inc. has a 1-year low of $67.30 and a 1-year high of $89.05. The business has a fifty day moving average price of $83.47 and a 200-day moving average price of $81.01. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a market capitalization of $56.63 billion, a P/E ratio of 13.70, a P/E/G ratio of 0.64 and a beta of 1.07.
MetLife Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 11th. Shareholders of record on Tuesday, February 4th will be issued a $0.545 dividend. This represents a $2.18 dividend on an annualized basis and a yield of 2.67%. The ex-dividend date is Tuesday, February 4th. MetLife’s dividend payout ratio is 36.52%.
Analyst Ratings Changes
Several equities research analysts have commented on the company. BMO Capital Markets assumed coverage on MetLife in a report on Thursday, January 23rd. They issued a “market perform” rating and a $97.00 target price on the stock. TD Cowen boosted their target price on MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. JPMorgan Chase & Co. boosted their target price on MetLife from $86.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Finally, Wells Fargo & Company dropped their target price on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a report on Tuesday, January 14th. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $92.17.
Get Our Latest Stock Analysis on MET
About MetLife
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Recommended Stories
- Five stocks we like better than MetLife
- High Flyers: 3 Natural Gas Stocks for March 2022
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- Top Stocks Investing in 5G Technology
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- How to Evaluate a Stock Before Buying
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.